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 February 2020 Newsletter 
 
 
CONGRATULATIONS!  
Congratulations to Dr. Paula Gardiner, MD, MPH, one of CAPCaT’s 2019 award recipients! A recent study 
by UMass Medical integrative medicine expert Dr. Gardiner finds that patients with chronic pain and 
depression who participated in medical group visits in which they learned mindfulness techniques were 
able to reduce their use of pain medications and made fewer emergency room visits. Read more about 
her success here. 
 
 
FUNDING 
CCTS SPARK Program (Small Pilot and Research Knowledge) 
CCTS Small Conference Grants 
CAPCaT Call for Solicitation-Expression of Interest: Due by March 2, 2020 
Charles A. King Trust Postdoctoral Research Fellowship Program: March 4, 2020 
MCCISS K12 Training Grants: Full Applications Due March 9, 2020 
 
 
CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to support studies 
that impact clinical care and research methodologies, support students/trainees, and provide access to 
funds to generate pilot and preliminary data for external grant submissions.  For more information, click 
on this link: https://www.umassmed.edu/ccts/funding/spark-program/ 
 
CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding facilitates the 
development of faculty-to-faculty networks within the University system.  Click on this link for more 
information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
CAPCaT CALL FOR SOLICITATION: EXPRESSION OF INTEREST: The University of 
Massachusetts’ Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and 
Sleep Diseases has grant funding available to bring your innovation to the next level! If you are working 
on a compelling point-of-care technology, including complementary and integrative health solutions for 
heart, blood, lung and sleep, you will want to seize this opportunity! Submit your Expression of Interest 
here.  The deadline to submit is March 2, 2020. 
 
CHARLES A. KING TRUST POSTDOCTORAL RESEARCH FELLOWSHIP PROGRAM: Apply NOW for the 
2020 Postdoctoral Research Fellowship Program in Basic Science and/or Clinical/Health Services 
Research. Application deadline is March 4, 2020 at 12:00pm EST.  The Charles A. King Trust was 
created to support and promote the investigation of human disease and the alleviation of human 
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suffering through improved treatment. The primary goal is to provide fellowships to Massachusetts’ 
postdoctoral fellows to investigate the causes of diseases in human beings and/or improve methods of 
treatment for human diseases. US citizenship is not required. Two-year grants ranging from $104,008 to 
$117,760 inclusive of a $2,000 expense allowance will be awarded September 1, 2020.  For application 
guidelines and templates, click here. For terms of the awards, click here. The funding period will be 
September 1, 2020 through August 31, 2022. To reach the Grants Officer, contact Lindsey Carver, MA at 
lcarver@hria.org. 
 
MCCISS K12 TRAINING GRANTS: The Massachusetts Consortium for Cardiopulmonary Implementation 
Science Scholars (MCCISS) announces K12 training grants for 2020.  These grants are for junior faculty 
working in cardiopulmonary health. The grants provide support for two years of mentored research 
training in implementation science.  
 
MCCISS Important Dates:  
03.09.2020 Full Applications Due 
April 2020 Scholar Selection 
09.01.2020 Scholar Appointments 
 
For more information, please visit www.umassmed.edu/mcciss/  The Massachusetts Consortium for Cardiopulmonary 
Implementation Science Scholars is supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number 
K12HL138049. 
 
 
EDUCATION 
NIH Virtual Workshop on Data Metrics: February 19, 2020 
Biotech East Course: Spring 2020 
K Club: Ongoing 
PiPSS: Projects in Process Seminar Series 
Point-of-Care Technology Survey: Healthcare Provider Input Needed 
ACME POCT Clinical Needs Survey 
 
 
NIH VIRTUAL WORKSHOP ON DATA METRICS: February 19, 2020: The National Institutes of Health’s 
Office of Data Science Strategy will host a virtual workshop, on February 19, 2020 beginning at 9am, 
on assessing dataset and data resource value reach. The goal is to discuss core metrics, use cases, and 
best practices to better understand open data usage and impact. To register and/or learn more, click 
here. 
 
BIOTECH EAST COURSE SPRING 2020: Academic Scientists – Transition to a Job in Biotech, Medtech, or 
Pharma. Join this week-long, hands-on course to help you transition from lab work to a job in biotech, 
medtech, or pharma. Discover the business side of science, network extensively, and learn 
interdisciplinary skills through a team project. Of the 182 attendees in 2014-2017, 67% now have jobs in 
industry, regulatory affairs, or tech transfer. Scholarships are available. Sponsors include ASCB, Biogen, 
KGI, M2D2, UMass Lowell, UMMS, UMCCTS, and CAPCaT. Complete details and application can be found 
here. 
 
 
2
UMass Center for Clinical and Translational Science Newsletter, Vol. 2020 [2020], Iss. 2, Art. 1
https://escholarship.umassmed.edu/umccts_news/vol2020/iss2/1
DOI: 10.13028/m59b-r893
EVENTS 
PMM In-House Seminar Series Guangping Gao, PhD: February 3, 2020 
M2D2 9th Annual $200k Challenge: Feb-April 2020 
PMM In-House Seminar Series Geraldine Seydoux, PhD: February 13, 2020 
Collaboration Webinar-Ensuring Quality: A Pilot Study to Establish a Monitoring Pool for 
Investigator Initiated Trials: February 19, 2020 
Un-Meeting on Lifespan and Life Course Research - Integrating Strategies: March 2, 2020 
9th Annual Community Engagement & Research Symposium: March 20, 2020 
GSBS Seminar Series Mary Woolley, President/CEO of Research! America: March 26, 2020 
Translational Science 2020: April 14-17, 2020 
RNA Therapeutics Symposium From Concept to Clinic: June 24-26, 2020 (Abstracts due 02.28.20) 
 
 
PMM IN-HOUSE SEMINAR SERIES GUANGPING GAO, PhD: The Program in Molecular Medicine In-
House Seminar Series presents Guangping Gao, PhD, Professor, Microbiology & Physiological Systems, 
Penelope Booth Rockwell Professor in Biomedical Research, Co-Director, Li Weibo Institute for Rare 
Diseases Research, Director, Horae Gene Therapy Center and Vector Core “Recombinant Adeno-Associated 
Virus-Mediated In Vivo Gene Transfer: Biology, Applications, Challenges and Approaches” on Monday, 
February 3, 2020 at 12:00pm, in the Molecular Medicine Seminar Room, 3rd Floor, Biotech Two.  
 
M2D2 9th ANNUAL $200k CHALLENGE: Enter the 9th Annual M2D2 $200k Challenge for exposure to a 
whole host of strategic partners and investors and for a chance to win!  M2D2’s signature annual pitch 
competition is your chance to propel your idea to the next level – or to market! For all life sciences 
startups interested in entering M2D2’s 9th Annual Global Pitch Competition, apply to win! The application 
deadline is February 16, 2020.  Those applications invited to advance will participate in a Pitch 
Competition to be held at UMass Lowell on March 25, 2020.  The Awards Ceremony will take place at 
Mintz Levin, One Financial Center, Boston MA on April 7, 2020. To apply, click here. 
 
PMM IN-HOUSE SEMINAR SERIES GERALDINE SEYDOUX, PhD: The Program in Molecular Medicine In-
House Seminar Series presents Geraldine Seydoux, PhD, Sheldon Professor in Medical Discovery and 
HHML Investigator, Vice Dean for Basic Research, Department of Molecular Biology and Genetics, Johns 
Hopkins University School of Medicine “How Do RNA Granules Get Their RNA? Regulation of RNA Granule 
Assembly by Intrinsically-Disordered Proteins” on Thursday, February 13, 2020 at 4:00pm, in the 
Molecular Medicine 3rd Floor Seminar Room, Biotech Two.  
 
COLLABORATION WEBINAR-ENSURING QUALITY: A PILOT STUDY TO ESTABLISH A MONITORING 
POOL FOR INVESTIGATOR INITIATED TRIALS: Sponsored by Southern California CTSI, the Trial 
Innovation Network presents this seminar/on-line self-study module that can be used to establish a 
monitoring pool to promote data integrity/reliability and subject protection.  Dr. Eunjoo Pacifici, PharmD, 
PhD, and her team will share their experiences from a pilot program to train a nucleus of senior 
coordinators in trial monitoring using the module.  The webinar is scheduled for February 19, 2020 at 
12:00 EST.  To register, please click here. 
 
UN-MEETING ON LIFESPAN AND LIFE COURSE RESEARCH – INTEGRATING STRATEGIES: Please join 
host Northwestern University of Chicago, in conjunction with CLIC, for the seminar Un-Meeting on 
Lifespan and Life Course Research – Integrating Strategies to be held on March 2, 2020 from 8am to 4pm 
at the Northwestern Medicine Prentice Women’s Hospital in Chicago.  Representatives from every CTSA 
hub will engage in robust dialogue about effective strategies for engaging in research across the lifespan 
and life course. The aim is to explore, enhance and disseminate strategies for lifespan and life course 
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research study design. A welcome reception will be held on Sunday, March 1, 2020 from 5m to 8pm at the 
Ann& Robert H. Lurie Children’s Hospital of Chicago.  For more information, please click here.   
 
9th ANNUAL COMMUNITY ENGAGEMENT & RESEARCH SYMPOSIUM: The 9th Annual Community 
Engagement & Research Symposium will be held on March 20, 2020. The breakout sessions serve as an 
opportunity to learn about innovative initiatives from community-engaged research teams from within 
the UMass system, as well as from local communities, other academic institutions, and beyond. Breakout 
sessions will be 60 minutes and include interactive discussion. To learn more about the symposium and 
previous breakout sessions, click here. Registration is now open. For additional information, email Karen 
Del’Olio at Karen.Del’Olio@umassmed.edu. 
 
GSBS SEMINAR SERIES MARY WOOLLEY, PRESIDENT/CEO OF RESEARCH! AMERICA: Please join us 
Thursday, March 26 at 3:00pm in the ASC Auditorium (reception to follow) as Mary Woolley, 
President/CEO of Research! America discusses the importance of advocacy for the promotion, protection, 
and preservation of research funding. To learn more about Research! America, click here. 
 
TRANSLATIONAL SCIENCE 2020: At Translational Science 2020, we want to shine a spotlight on the 
most innovative, forward-thinking research in the field.  Share your original research and help us create a 
meeting where people can enhance their personal development and learning process. Abstracts will be 
accepted in the following tracks: basic; methodology; data science; biostatistics; informatics; 
commercialization; entrepreneurship; digital health; social media; education; mentoring; professional 
and career development; health equity; community engagement; mechanistic basic to clinical; regulatory 
science; team science; translational science; policy and health outcomes science. To learn more about 
Translational Science 2020 to be held in Washington DC April 14-17, 2020, click here.  
 
RNA THERAPEUTICS SYMPOSIUM-FROM CONCEPT TO CLINIC: Registration for the 2nd Annual RNA 
Therapeutics From Concept to Clinic to be held June 24-26, 2020 is now open.  Keynote speakers are 
Katherine High, President/Head of Research and Development of Spark Therapeutics and Michael 
Rosbash, Peter Gruber Endowed Chair in Neuroscience, Professor of Biology HHMI, Brandeis University.                  
To learn more and reserve your spot, click here. Register before April 3, 2020 and receive an early bird 
discount!  For abstract submissions, click here. 
 
 
DID YOU KNOW? 
ClinicalTrials.gov Request for Information: March 14, 2020 
CTSA Regulatory Expertise 
Diamond Portal  
HRPP QA/QI 
UMMS Institutional Review Board 
National Center for Data to Health (CD2H) 
Next Generation Blood Products RFI 
Recruitment and Retention Toolkit 
 
CLINICALTRIALS.GOV: ClinicalTrials.gov is seeking your input!  As they celebrate 20 years, they seek to 
modernize their platform to deliver an improved user experience that will accommodate growth and 
enhance efficiency. To do so requires your input and feedback.  To access their Request for Information 
(RFI), please click here.  They are specifically soliciting comments on the following topics: website 
functionality, information submission processes, and use of data standards.  The deadline to provide your 
input is March 14, 2020. 
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CTSA REGULATORY EXPERTISE: Three North Carolina Clinical and Translational Science Awards 
(CTSA) Program hubs have collaborated to create a platform for sharing regulatory expertise and best 
practices. The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) Program 
provides researchers with regulatory guidance, education, and consultative support, to ultimately help 
them move promising products and novel discoveries to clinical trials. 
  
ReGARDD, which is coordinated by Duke University, the Wake Forest School of Medicine, and the 
University of North Carolina at Chapel Hill hubs with partner RTI International, officially launched in 
2015 and has been developing since. The program builds upon the existing services and knowledge of the 
North Carolina CTSA Program Regulatory Groups and the Research Triangle Park (RTP). 
 
Read the full story here.  Visit the ReGARDD website here. 
 
DIAMOND PORTAL: To address the need for consistent training assessment and measures of 
competency, the Michigan Institute for Clinical & Health Research (MICHR) has collaborated with the 
Ohio State University, Rochester University, and Tufts University to launch the DIAMOND Portal. It is a 
pioneering digital collection that serves as a sustainable, federated database for members of clinical and 
translational research study teams to share and access training and assessment resources. For more 
information, visit https://www.michr.umich.edu/news/2018/10/15/new-diamond-portal-allows-ctsa-
members-to-access-share-training-and-assessment-materials 
 
HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and Translational 
Science. The program is independent of the IRB and helps study teams and investigators by conducting 
routine post-approval monitoring of on-going research to evaluate adherence with institutional 
requirements and federal regulations. If there are review findings, the QA/QI manager shares those 
findings with investigators and study teams, and provides direct education on the findings, including how 
to avoid making similar errors in the future. In order to support improvement at an institutional level, the 
QA/QI manager shares aggregated data from reviews with the HRPP leadership and the Research 
Community to identify trends and target areas for education. The program also makes self-evaluation 
tools available to investigators and study teams seeking to perform their own assessments.  To learn 
more about HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
UMMS INSTITUTIONAL REVIEW BOARD (IRB): The UMMS IRB manages over 1,000 active protocols, 
including reviewing and approving more than 600 modifications annually.  2019 brought a 41% increase 
in the number of exempt studies, as UMMS investigators began taking advantage of new and expanded 
exemption categories in the Revised Common Rule.  The UMMS IRB has entered into 400+ reliance 
agreements, serving as reviewing or relying IRB, starting with just two in 2004 and growing to roughly 
50 per year for each of the past five years. 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data more 
meaningful, open and accessible. The CD2H supports a vibrant and evolving collaborative informative 
ecosystem for the CTSA program and beyond. The CD2H harnesses and expands an ecosystem for 
translational scientists to discover and share their software, data and other research resources within the 
CTSA program network.  The CD2H also creates a social coding environment for translational science 
institutions, leveraging the community-driven DREAM challenges as a mechanism to stimulate 
innovation. To learn more, click here. 
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NEXT GENERATION BLOOD PRODUCTS RFI: The Office of the Assistant Secretary for Preparedness and 
Response (ASPR) leads the nation in preventing, preparing for, responding to, and recovering from the 
adverse health effects of emergencies and disasters by supporting our communities’ ability to withstand 
adversity, strengthening our health and response systems, and enhancing national health security. Within 
the ASPR, the Biomedical Advanced Research and Development Authority (BARDA) provides an 
integrated, systematic approach to the development and procurement of necessary vaccines, drugs, 
therapies, and diagnostic tools for public health medical emergencies.  Together, the ASPR and BARDA 
are issuing this Request for Information (RFI) to assist in understanding the developmental landscape of 
next generational blood products that could be used to treat mechanical trauma and bleeding associated 
with acute radiation syndrome and potentially supplement the blood supply in the wake of a mass 
casualty event.  To learn more about this RFI and/or to submit a response, please click here. 
 
RECRUITMENT AND RETENTION TOOLKIT: The Trial Innovation Network accepts toolkit submissions 
from CTSAs and reputable community health partners and provides them as a free resource to the 
research community.  The materials on this site are designed primarily for CTSA program staffs. These 
resources are intended to provide a variety of information that includes best practices and evidence-
based recruitment and retention strategies. Full information can be found at 
https://trialinnovationnetwork.org/recruitment-retention-toolkit/?key-element=1681 
 
 
SHARE YOUR SUCCESS STORY 
Have you had your research published that cites the UMass Center for Clinical and Translational Science?  
Has your patent been filed on technology developed using Center funding or resources? Did your pilot 
project receive external grant funding? Share it with us at ccts@umassmed.edu. Sharing your success 
demonstrates the importance and effect of the Center for Clinical and Translational Science at UMass. 
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send announcements, 
including a link, to ccts@umassmed.edu.  The newsletter is published the first week of each month. 
 
 
PLEASE REMEMBER TO CITE in all presentations and journal publications:  
UMCCTS funded by NCATS Grants UL1 TR001453, TL1 TR001454, and KL2 TR001455. 
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